Skip to content

The Impact of Esmolol Administration on Postoperative Recovery

The Effect of Intraoperative Esmolol Administration on Postoperative Recovery and Chronic Pain

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05567822
Acronym
esmolol
Enrollment
70
Registered
2022-10-05
Start date
2022-10-01
Completion date
2024-10-01
Last updated
2022-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Acute, Pain, Postoperative, Pain, Chronic Post-Surgical, Esmolol, Inguinal Hernia Repair, Analgesia, Nociceptive Pain

Brief summary

The aim of this study will be to investigate the effect of a continuous infusion of low dose esmolol on intraoperative and postoperative opioid consumption, as well as on postoperative recovery and chronic pain

Detailed description

Contemporary anaesthesiology requires the quest of ways to restrict the use of opioids, which aim at the alleviation of severe postoperative and chronic pain. This is not only due to the side effects involved but also to the epidemic dimensions their use entails. Esmolol, an extremely short-acting cardioselective antagonist of β1 adrenergic receptors, is effectively used in order to attenuate the stress response and minimize undesirable perioperative hemodynamic changes. More specifically, esmolol has been used effectively to reduce pain during induction of anesthesia with propofol and treat tachycardia and hypertension during laryngoscopy. However, recent studies also highlight a possible antinociceptive and/or analgesic effect of esmolol. Therefore, The aim of this study will be to investigate the effect of a continuous infusion of low dose esmolol on intraoperative and postoperative opioid consumption, as well as on postoperative recovery and chronic pain

Interventions

In the esmolol group, patients will receive a bolus dose of esmolol followed by a continuous infusion of esmolol intraoperatively

DRUGnormal saline

In the placebo group, patients will receive a bolus dose of normal saline followed by a continuous infusion of normal saline intraoperatively

Sponsors

Aretaieion University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* adult patients * American Society of Anesthesiologists (ASA) classification I-II * elective inguinal hernia repair

Exclusion criteria

* body mass index (BMI) \>35 kg/m2 * β-blocker administration preoperatively * systematic use of analgesic agents preoperatively * chronic pain syndromes preoperatively * neurological or psychiatric disease on treatment * pregnancy * severe hepatic or renal disease * history of cardiovascular diseases/ arrhythmias/ conduction abnormalities * hemodynamic instability * drug or alcohol abuse * language or communication barriers * lack of informed consent * bilateral inguinal hernia repair

Design outcomes

Primary

MeasureTime frameDescription
pain score 3 hours postoperatively3 hours postoperativelypain score by the use of Numeric Rating Scale (NRS) 3 hours postoperatively, ranging from 0 to 10, where 0 means no pain and 10 means worst pain imaginable
pain score 6 hours postoperatively6 hours postoperativelypain score by the use of Numeric Rating Scale (NRS) 6 hours postoperatively, ranging from 0 to 10, where 0 means no pain and 10 means worst pain imaginable
pain score 24 hours postoperatively24 hours postoperativelypain score by the use of Numeric Rating Scale (NRS) 24 hours postoperatively, ranging from 0 to 10, where 0 means no pain and 10 means worst pain imaginable

Other

MeasureTime frameDescription
time to first request for analgesiaduring stay in Post-Anesthesia Care Unit (PACU), approximately 1 hour postoperativelythe time for the first patient request for analgesia will be noted
morphine consumption in Post-Anesthesia Care Unit (PACU)immediately postoperativelymg of morphine requested during patient PACU stay
tramadol consumption in the first 24 hours24 hours postoperativelypatients will be followed for cumulative tramadol consumption for 24 hours postoperatively
fentanyl requirement during surgeryintraoperativelydose of required fentanyl intraoperatively to maintain systolic arterial blood pressure and heart rate within the 20% of baseline value
time to emergenceup to 2 hours after start of surgerytime from sevoflurane discontinuation to first patient response (eye opening)
time to extubationup to 2 hours after start of surgerytime from sevoflurane discontinuation to tracheal extubation
Post Anesthesia Care Unit (PACU) duration of stayimmediately postoperativelyduration of patient stay at PACU
sedation on arrival to Post-Anesthesia Care Unitimmediately postoperativelysedation will be assessed with a 5-point sedation scale, where: 1, patient perfectly conscious; 2, patient feels a little drowsy; 3, patient seems to be sleeping but immediately reacts to verbal stimulation; 4, patient seems to be sleeping but slowly reacts to verbal stimulation and 5, patient seems to be sleeping and does not react to verbal stimulation but does react to a stimulus such as shaking or pain
sedation at discharge from Post-Anesthesia Care (PACU) Unitat discharge from Post Anesthesia Care Unit (PACU), approximately 1 hour postoperativelysedation will be assessed with a 5-point sedation scale, where: 1, patient perfectly conscious; 2, patient feels a little drowsy; 3, patient seems to be sleeping but immediately reacts to verbal stimulation; 4, patient seems to be sleeping but slowly reacts to verbal stimulation and 5, patient seems to be sleeping and does not react to verbal stimulation but does react to a stimulus such as shaking or pain
side effects postoperatively48 hours postoperativelypatients will be monitored for side-effects of the administered agents postoperatively
satisfaction from analgesiaat discharge from Post Anesthesia Care Unit, approximately 1 hour postoperativelysatisfaction from postoperative analgesia on a four-point Likert scale with 1 marked as minimal satisfaction and 4 as maximal satisfaction
change from baseline in Quality of Recovery (QoR)-15 score after surgery24 hours postoperativelyThe QoR-15 is a quality of recovery scale that consists of 15 questions (items),including questions regarding pain (2 items), physical comfort (5 items), self-care ability (2 items), psychological support (2 items) and emotional state (4 items). Every item is scored on a scale of 10, with the lowest total score of 0 and the highest score of 150. The higher the score, the better the recovery quality of the patient
pain score on arrival to Post-Anesthesia Care Unit (PACU)immediately postoperativelypain score by the use of Numeric Rating Scale (NRS) on arrival to PACU, ranging from 0 to 10, where 0 means no pain and 10 means worst pain imaginable
first mobilization after surgery24 hours postoperativelypatients will be questioned regarding the time at which they mobilized after surgery
gastrointestinal recovery after surgery24 hours postoperativelypatients will be questioned regarding the time they first felt enteral sounds and the time they had their first flatus after surgery
first fluid intake24 hours postoperativelypatients will be questioned regarding the time they had their first fluid intake
first solid intake24 hours postoperativelypatients will be questioned regarding the time they had their first solid intake
hospitalization time96 hours postoperativelyduration of hospital stay after surgery in hours
incidence of chronic pain 1 month after surgery1 month after surgeryoccurrence of chronic pain at the site of the operation 1 month after surgery, with the use of the Numeric Rating Scale (NRS), at rest and during movement
incidence of chronic pain 3 months after surgery3 months after surgeryoccurrence of chronic pain at the site of the operation 3 months after surgery, with the use of the Numeric Rating Scale (NRS), at rest and during movement
duration of nociception level<25 intraoperativelyintraoperativelynociception level (NOL) is a device that measures the status of analgesia intraoperatively. Levels\<25 suggest adequate intraoperatively analgesia
change from baseline in cortisol levels after surgeryduring patient stay in the Post Anesthesia Care Unit, approximately 2 hours postoperativelyblood samples will be collected to measure the variation in cortisol levels from the induction of anesthesia till the arrival of the patient to the Post Anesthesia CAre Unit
change from baseline in prolactin levels after surgeryduring patient stay in the Post Anesthesia Care Unit, approximately 2 hours postoperativelyblood samples will be collected to measure the variation in prolactin levels from the induction of anesthesia till the arrival of the patient to the Post Anesthesia CAre Unit
change from baseline in lactate levels after surgeryduring patient stay in the Post Anesthesia Care Unit, approximately 2 hours postoperativelyblood samples will be collected to measure the variation in lactate levels from the induction of anesthesia till the arrival of the patient to the Post Anesthesia CAre Unit
sleep quality24 hours postoperativelysubjective evaluation of sleep quality by patients, based on a sleep questionnaire (evaluation of sleep duration, number of nocturnal awakenings and marking of sleep quality)
pain score at discharge from Post-Anesthesia Care Unit (PACU)at discharge from Post Anesthesia Care Unit (PACU), approximately 1 hour postoperatively]pain score by the use of Numeric Rating Scale (NRS) at discharge from PACU, ranging from 0 to 10, where 0 means no pain and 10 means worst pain imaginable
sevoflurane consumption during general anesthesiachange of sevoflurane vaporizer weight from before induction to end of anesthesia, an average period of 1-2 hoursthe sevoflurane vaporizer will be weighed before anesthetic induction and at the end of anesthesia and consequently sevoflurane consumption during anesthesia will be determined

Countries

Greece

Contacts

Primary ContactKassiani Theodoraki, PhD, DESA
ktheodoraki@hotmail.com+306974634162
Backup ContactVasiliki Samartzi
v.samartzi2@gmail.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026